000			02088 a2200601 4500
005			20250516221838.0
264		0	_c20150220
008			201502s 0 0 eng d
022			_a1473-5571
024	7		_a10.1097/QAD.0000000000000131 _2doi
040			_aNLM _beng _cNLM
100	1		_aCooper, David A
245	0	0	_aEfficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. _h[electronic resource]
260			_bAIDS (London, England) _cMar 2014
300			_a717-25 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlkynes
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntiretroviral Therapy, Highly Active _xadverse effects
650	0	4	_aBenzoxazines _xadverse effects
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCyclohexanes _xadverse effects
650	0	4	_aCyclopropanes
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xisolation & purification
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMaraviroc
650	0	4	_aMiddle Aged
650	0	4	_aTreatment Outcome
650	0	4	_aTriazoles _xadverse effects
650	0	4	_aViral Load
650	0	4	_aYoung Adult
700	1		_aHeera, Jayvant
700	1		_aIve, Prudence
700	1		_aBotes, Mariette
700	1		_aDejesus, Edwin
700	1		_aBurnside, Robert
700	1		_aClumeck, Nathan
700	1		_aWalmsley, Sharon
700	1		_aLazzarin, Adriano
700	1		_aMukwaya, Geoffrey
700	1		_aSaag, Michael
700	1		_avan Der Ryst, Elna
773	0		_tAIDS (London, England) _gvol. 28 _gno. 5 _gp. 717-25
856	4	0	_uhttps://doi.org/10.1097/QAD.0000000000000131 _zAvailable from publisher's website
999			_c23970736 _d23970736